Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
Raskob G, Büller H, Prins M, Segers A, Shi M, Schwocho L, van Kranen R, Mercuri M; Hokusai-VTE Investigators. Raskob G, et al. Among authors: buller h. J Thromb Haemost. 2013 Jul;11(7):1287-94. doi: 10.1111/jth.12230. J Thromb Haemost. 2013. PMID: 23574579 Free article. Clinical Trial.
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Verhamme P, Wells PS, Segers A, Ageno W, Brekelmans MP, Cohen AT, Meyer G, Grosso MA, Raskob G, Weitz JI, Zhang G, Buller H. Verhamme P, et al. Among authors: buller h. Thromb Haemost. 2016 Sep 27;116(4):747-53. doi: 10.1160/TH16-03-0244. Epub 2016 Jul 21. Thromb Haemost. 2016. PMID: 27440518 Clinical Trial.
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.
Botticelli Investigators, Writing Committe; Buller H, Deitchman D, Prins M, Segers A. Botticelli Investigators, Writing Committe, et al. Among authors: buller h. J Thromb Haemost. 2008 Aug;6(8):1313-8. doi: 10.1111/j.1538-7836.2008.03054.x. Epub 2008 Jun 6. J Thromb Haemost. 2008. PMID: 18541000 Free article. Clinical Trial.
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Davidson BL, Büller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Lensing AW; Matisse Investigators. Davidson BL, et al. Among authors: buller hr. J Thromb Haemost. 2007 Jun;5(6):1191-4. doi: 10.1111/j.1538-7836.2007.02565.x. J Thromb Haemost. 2007. PMID: 17403087 Free article. Clinical Trial.
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
Mulder FI, van Es N, Kraaijpoel N, Di Nisio M, Carrier M, Duggal A, Gaddh M, Garcia D, Grosso MA, Kakkar AK, Mercuri MF, Middeldorp S, Royle G, Segers A, Shivakumar S, Verhamme P, Wang T, Weitz JI, Zhang G, Büller HR, Raskob G. Mulder FI, et al. Among authors: buller hr. Thromb Res. 2020 Jan;185:13-19. doi: 10.1016/j.thromres.2019.11.007. Epub 2019 Nov 9. Thromb Res. 2020. PMID: 31733403
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial.
Verhamme P, Tangelder M, Verhaeghe R, Ageno W, Glazer S, Prins M, Jacquemin M, Büller H; TB-402 Study Group. Verhamme P, et al. Among authors: buller h. J Thromb Haemost. 2011 Apr;9(4):664-71. doi: 10.1111/j.1538-7836.2011.04221.x. J Thromb Haemost. 2011. PMID: 21284801 Free article. Clinical Trial.
985 results